Exposome-Scan is a strategic collaboration between Leiden University/LACDR and the Institute of Risk Assessment Sciences at Utrecht University to advance exposome research by offering state-of-the art or even beyond state-of-the-art services to academic, clinical and industrial researchers.
The overall aims of Exposome‐Scan are:
Exposome-Scan is lead by a core team:
Prof.dr. Thomas Hankemeier (development of analytical strategies for metabolomics-driven health monitoring and systems biology studies).
Chair of Metabolomics and Analytics Centre, Leiden University
Prof.dr. Roel Vermeulen (exposome research, risk assessment, epidemiology).
Chair of the Institute for Risk Assessment Sciences. Director of the Utrecht Exposome Hub, Utrecht University
Prof.dr. Bob van de Water (safety and toxicity, in vitro models, high content imaging)
Chair of Division of Drug Discovery & Safety, Leiden University
Dr. Amy Harms (metabolomics, mass spectrometry, metabolite identification, high throughput analysis)
Head Biomedicial Metabolomics Facility Leiden, Metabolomics and Analytics Centre, Leiden University
Dr. Sylvia Le Dévédec (high content imaging, safety, in vitro models)
Head Cell Observatory, Leiden University